GM2 activator protein deficiency, mimic of Tay-Sachs disease

Abstract

GM2 Gangliosidoses are a group of autosomal recessive genetic disorders caused by intra-lysosomal deposition of ganglioside GM2 mainly in the neuronal cells. GM2-Activator protein deficiency is an extremely rare type of GM2 gangliosidosis (AB variant) caused by the mutation of GM2A.We report a case of a female child who presented with clinical features similar to classical Tay-Sachs disease, but with normal beta hexosaminidase enzyme levels. Molecular study revealed a novel homozygous intronic mutation which confirmed the diagnosis of GM2 Activator protein deficiency. GM2 Activator protein deficiency is a mimic of Classical Tay-Sachs disease and should be a differential diagnosis in children who present with neuroregression, cherry red spots without hepatosplenomegaly and with normal beta hexosaminidase enzyme levels.

Keywords

GM2 Gangliosidoses - GM2-Activator protein - GM2A - Cherry red spots - Tay-Sachs disease

• References

• 1 Gravel RA, Clarke JTR, Kaback MM. et al. The GM2 gangliosidoses. Scriver CR, Beaudet AL, Sly WS, Valle D. The Metabolic and Molecular Bases of Inherited Disease. 7th ed.. 1995. McGraw-Hill; New York: 2839-2879
• 2 Sakuraba H, Itoh K, Shimmoto M. et al. GM2 gangliosidosis AB variant. Clinical and biochemical studies of a Japanese patient. Neurology 52 1999; 372-377
• 3 Schroder M, Schnabel D, Suzuki K. et al. A mutation in the gene of a glycolipid binding protein (GM2activator) that causes GM2 gangliosidosis variant AB. FEBS Lett 290 1991; 1-3
• 4 Xie B, Wang W, Mahuran DJ. A cys138-to-Arg substitution in the GM2 activator protein is associated with the AB variant form of GM2 gangliosidosis. Am J Hum Genet 50 1992; 1046-1052
• 5 Schroder M, Schnabel D, Hurwitz R. et al. Molecular genetics of GM2 gangliosidosis AB variant: a novel mutation and expression in BHK cells. Hum Genet 92 1993; 437-440
• 6 Schepers U, Glombitza G, Lemm T. et al. Molecular analysis of a GM2-Activator deficiency in two patients with GM2-Gangliosidosis AB variant. Am J Hum Genet 59 1996; 1048-1056
• 7 Chen B, Rigat B, Curry C. et al. Structure of the GM2A gene: identification of an exon 2 nonsense mutation and a naturally occurring transcript with an In-frame deletion of exon 2. Am J of Hum Genet 65 1999; 77-87
• 8 Kolodny E, Sathe S, Zeng BJ. et al. A novel GM2- activator deficiency mutation as a cause of AB variant GM2-Gangliosidosis. Mol Genet Metab 93 2008; 27-28
• 9 Renaud D, Brodsky M. GM2-Gangliosidosis, AB variant: clinical, opthalmological, MRI and molecular findings. JIMD Rep 25 2016; 83-86
• 10 Kustermann W, Brackmann F, Gusek-Schneider G. et al. Rare variant of GM2 gangliosidosis due to activator protein deficiency: a case report. Neuropediatrics 46 2015; PS01-PS21
• 11 Sheth J, Datar C, Mistri M. et al. GM2 gangliosidosis AB variant: novel mutation from India −a case report with a Review. BMC Pediatr 16 2016; 88
• 12 Burg J, Conzelmann E, Sandhoff K. et al. Mapping of the gene coding for the human GM2 activator protein to chromosome 5. Ann Hum Genet 49 1985; 41-45
• 13 Wright CS, Li SC, Rastinejad F. Crystal structure of human GM2-activator protein with a novel beta-cup topology. J Mol Biol 304 2000; 411-422
• 14 Hama Y, Li Y, Li SC. Interaction of GM2 activator protein with glycospingolipids. J Biol Chem 272 1997; 2828-2833